VIRMA and cancer: We further conducted survival analysis in multiple cancer cohorts including ACC, BLCA, BRCA, ESCA, LGG, LIHC, PAAD, THCA, and UCEC patients in TCGA and found that high expression of KIAA1429 was significantly associated with poorer OS in patients.